Integrated Metabolome and Lipidome Strategy to Reveal the Action Pattern of Paclobutrazol, a Plant Growth Retardant, in Varying the Chemical Constituents of Platycodon Root
Round 1
Reviewer 1 Report
Dear Editors, dear authors,
the manuscript
"Integrated Metabolome and Lipidome Strategy to Reveal the Action
Pattern of Paclobutrazol, a Plant Growth Retardant, in Varying the Chemical
Constituents of Platycodon Root"
represents an interesting and solidly presented review paper. After revising it according to my minor comments below, I recommend for publication.
COMMENTS
Line 17
in paclobutrazol treated sample --> in a with paclobutrazol treated sample
Line 19-20
explaining the exogenous matter influence --> explaining that the exogenous matter influences
Figure 2
Increase font sizes and image resolution
Table 1
How was the identification of compounds done? By which software? By database matches?
Line 125
positive and negative mode --> positive and negative ionization mode (I believe this is meant here)
Line 137
Lipid is one of --> Lipids are one of
Line 166
How are total saponins defined?
Line 186
Similarly, polysaccharides and oligosaccharides represent a group of compounds. How were they defined here?
Line 257
Please give a reference
Author Response
Please see the attachment.
Author Response File: Author Response.docx
Reviewer 2 Report
This manuscript evaluated effect of Paclobutrazol, a Plant Growth Retardant, in chemical composition of Platycodon Root by metabolomics and lipidomics approaches. Authors comprehensively compared amounts of metabolites and lipids using UPLC-IM-QToF-MS. Additionally, using UV and ELSD, total amounts of saponin and polysaccharides were compared. Overall, the study is very interesting however some of the experimental procedure was not explained in detail. Additionally, there are some grammatical errors which requires authors to receive English editing from native speakers.
Here are some of my points.
1. In metabolomics study, author did not mention about the quality control method during the analysis. They did not mention usage of internal standard or normalization strategies to control the sample variabilities which could occur during the analysis procedure. Please mention about the method used to increase the quality of metabolomics result. Additionally, in Figure 3 authors compared intensities of total saponin based on types. Please describe how the total abundance has been calculated. If it is just sum of intensities of saponin peaks, it may not be right way to compare the level of total saponin based on each class, since each compounds have different sensitivities when analyzed by mass spectrometer.
2. Authors compare the total saponins by HPLC-ELSD and they did not describe the method but just referring to EP 10.0. Please describe which solvent condition used, and which standard is used for the quantification of total saponin, since some of readers may not have access to European Pharmacopoeia. Same for Oligosaccharide UHPLC-ELSD method. They mentioned previous method regarding calibration curve, but they did not mention about which mobile phase and analytical column has been used.
3. In Table 2, authors compared content of control and paclobutrazol treated groups. This table seems to compare control with 2-year and treated group with 3-year, which is not comparing the plant with same age. If this is the case, result may be misleading by doing wrong sampling. Please check again.
Minor points
-Page 3, Line 80: Figure 1 caption; root diameter (a) and weight (b) à root diameter (b) and weight (c)
-Page 3, Line 93: In consequently à Collectively,
-Page 3, Line 99: rising contents à Rephrase the sentences and words
-Page 3, Line 113: “type” is redundant
Author Response
Please see the attachment.
Author Response File: Author Response.docx
Round 2
Reviewer 2 Report
Authors have clearly responded to reviewer's comments.
There is one minor suggestion to authors.
Authors mentioned usage of QC samples to control the variability during analysis. I would recommend authors to add PCA plot with QC samples in supplementary files to prove the validity of analysis.
Author Response
Please see the attachment.
Author Response File: Author Response.docx